162 related articles for article (PubMed ID: 22643967)
1. Fractal dimension as a measure of surface roughness of G protein-coupled receptors: implications for structure and function.
Kaczor AA; Guixà-González R; Carrió P; Obiol-Pardo C; Pastor M; Selent J
J Mol Model; 2012 Sep; 18(9):4465-75. PubMed ID: 22643967
[TBL] [Abstract][Full Text] [Related]
2. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
Dalton JA; Lans I; Giraldo J
BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
4. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
Bhattacharya S; Hall SE; Li H; Vaidehi N
Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure.
Roth CB; Hanson MA; Stevens RC
J Mol Biol; 2008 Mar; 376(5):1305-19. PubMed ID: 18222471
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
8. Ligand entry and exit pathways in the beta2-adrenergic receptor.
Wang T; Duan Y
J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
[TBL] [Abstract][Full Text] [Related]
9. Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
Simpson LM; Wall ID; Blaney FE; Reynolds CA
Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626
[TBL] [Abstract][Full Text] [Related]
10. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.
Bokoch MP; Zou Y; Rasmussen SG; Liu CW; Nygaard R; Rosenbaum DM; Fung JJ; Choi HJ; Thian FS; Kobilka TS; Puglisi JD; Weis WI; Pardo L; Prosser RS; Mueller L; Kobilka BK
Nature; 2010 Jan; 463(7277):108-12. PubMed ID: 20054398
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into agonist-induced activation of G-protein-coupled receptors.
Deupi X; Standfuss J
Curr Opin Struct Biol; 2011 Aug; 21(4):541-51. PubMed ID: 21723721
[TBL] [Abstract][Full Text] [Related]
12. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled receptors--recent advances.
Latek D; Modzelewska A; Trzaskowski B; Palczewski K; Filipek S
Acta Biochim Pol; 2012; 59(4):515-29. PubMed ID: 23251911
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures.
Madsen JJ; Ye L; Frimurer TM; Olsen OH
Protein Sci; 2022 Nov; 31(11):e4456. PubMed ID: 36134696
[TBL] [Abstract][Full Text] [Related]
15. Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.
Liu JJ; Horst R; Katritch V; Stevens RC; Wüthrich K
Science; 2012 Mar; 335(6072):1106-10. PubMed ID: 22267580
[TBL] [Abstract][Full Text] [Related]
16. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
[TBL] [Abstract][Full Text] [Related]
17. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
[TBL] [Abstract][Full Text] [Related]
18. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
[TBL] [Abstract][Full Text] [Related]
19. Lipid-binding surfaces of membrane proteins: evidence from evolutionary and structural analysis.
Adamian L; Naveed H; Liang J
Biochim Biophys Acta; 2011 Apr; 1808(4):1092-102. PubMed ID: 21167813
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
